FINDELL CAPITAL MANAGEMENT LLC — 13F Holdings & Portfolio

CIK 1814465 · latest 13F-HR filed 2026-05-15

FINDELL CAPITAL MANAGEMENT LLC manages $341.4M in 13F-reported U.S. long-equity assets across 18 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are LQDA (38.71%), ESTA (16.59%), DAVE (8.67%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 5 new positions, exited 3, added to 6, and trimmed 5.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM

$341.4M

Long-equity book

Holdings

18

Distinct positions

Period

2026-03-31

Filed 2026-05-15

Q/Q Activity

+5 / −3 / ↑6 / ↓5

vs 2025-12-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • LIQUIDIA CORPORATION$33.8M +34.4%
  • DAVE INC$14.1M +91.0%
  • ABIVAX SA$5.2M +80.6%
  • SUPER GROUP SGHC LIMITED$5.0M +44.2%
  • GEO GROUP INC$4.2M +40.4%
Show all 6

Top Trims

  • ESTABLISHMENT LABS HLDGS INC-$25.7M -31.2%
  • EHEALTH INC-$6.3M -96.4%
  • TURNING PT BRANDS INC-$5.5M -40.1%
  • CELSIUS HLDGS INC-$2.5M -26.1%
  • OPORTUN FINL CORP-$916.6K -6.7%
Show all 5

New Positions

  • CENOVUS ENERGY INC$9.9M
  • ACADIA HEALTHCARE COMPANY IN$8.9M
  • VERMILION ENERGY INC$5.1M
  • APPLIED DIGITAL CORP$4.0M
  • PEABODY ENGR CORP$276.2K
Show all 5

Exited Positions

  • STRIDE INC$5.8M
  • ADMA BIOLOGICS INC$5.5M
  • VOR BIOPHARMA INC$3.0M
Show all 3
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 LIQUIDIA CORPORATION LQDA 53635D202 $132.2M 38.71% 3,502,112 SH
2 ESTABLISHMENT LABS HLDGS INC ESTA G31249108 $56.7M 16.59% 997,747 SH
3 DAVE INC DAVE 23834J201 $29.6M 8.67% 170,000 SH
4 ROOT INC ROOT 77664L207 $16.6M 4.85% 375,000 SH
5 SUPER GROUP SGHC LIMITED SGHC G8588X103 $16.2M 4.74% 1,500,000 SH
6 GEO GROUP INC GEO 36162J106 $14.7M 4.31% 875,000 SH
7 OPORTUN FINL CORP OPRT 68376D104 $12.7M 3.71% 2,748,300 SH
8 ABIVAX SA ABVX 00370M103 $11.7M 3.42% 105,000 SH
9 CENOVUS ENERGY INC CVE 15135U109 $9.9M 2.91% 375,000 SH
10 ACADIA HEALTHCARE COMPANY IN ACHC 00404A109 $8.9M 2.60% 380,000 SH
11 TURNING PT BRANDS INC TPB 90041L105 $8.2M 2.41% 95,000 SH
12 CELSIUS HLDGS INC CELH 15118V207 $7.1M 2.08% 200,000 SH
13 MINERALYS THERAPEUTICS INC MLYS 603170101 $5.5M 1.60% 202,000 SH
14 VERMILION ENERGY INC VET 923725105 $5.1M 1.49% 370,000 SH
15 APPLIED DIGITAL CORP APLD 038169207 $4.0M 1.18% 170,000 SH
16 LIQUIDIA CORPORATION Call LQDA 53635D202 $1.9M 0.55% 50,000 SH
17 PEABODY ENGR CORP BTU 704551100 $276.2K 0.08% 8,381 SH
18 EHEALTH INC EHTH 28238P109 $230.9K 0.07% 179,027 SH
Filing History
Period Filed AUM Holdings Accession
2026-03-31 2026-05-15 $341.4M 18 0000921895-26-001410
2025-12-31 2026-02-17 $347.8M 17 0000921895-26-000470
2025-09-30 2025-11-14 $253.4M 15 0000921895-25-003108